Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.
about
Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcomaOsteosarcoma: Current Treatment and a Collaborative Pathway to SuccessAssociation of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database.Assessing the percent of necrosis after neoadjuvant chemotherapy with 24hr infusional cisplatin/3 days Doxorubicin intermittent with Ifosfamide-Doxorubicin for osteosarcoma.Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.Treatment pathway of bone sarcoma in children, adolescents, and young adultsSystematic review to determine whether participation in a trial influences outcomeCemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants.Cemented endoprosthetic reconstruction of the proximal tibia: how long do they last?The current practice of orthopaedic oncology in North America.Does increased rate of limb-sparing surgery affect survival in osteosarcoma?Low-grade fibromyxoid sarcoma of the hand: a case report.Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis.Lower limb salvage surgery: modular endoprosthesis in bone tumour treatmentFarnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cellsMifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomasType I and type III collagen metabolites in adult osteosarcoma patientsInhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment.Nimbolide Induces ROS-Regulated Apoptosis and Inhibits Cell Migration in OsteosarcomaPre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcomaThe Current and Future Therapies for Human Osteosarcoma.Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.Proliferative activity (ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases.Evolving gene therapy approaches for osteosarcoma using viral vectors: reviewShould contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases?Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center.IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.Active Targeting to Osteosarcoma Cells and Apoptotic Cell Death Induction by the Novel Lectin Eucheuma serra Agglutinin Isolated from a Marine Red Alga.Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.Radiation-induced meningeal osteosarcoma of tentorium cerebelli with intradural spinal metastases.SPC24 promotes osteosarcoma progression by increasing EGFR/MAPK signaling.The extremity localized classic osteosarcomas have better survival than the axial non-classics.
P2860
Q24814867-548DC48D-68CF-4983-AF83-889855587123Q26797555-820CD1A4-EE53-4AFD-83FC-AD15A0909CE7Q33274663-EA6D99F2-B197-4EC8-B9D4-CED28F4E2134Q33413207-1B848387-69CB-4048-A75F-A1A483089C5FQ33555060-8DF3F77D-F7DF-432E-B847-30038F331BA4Q33835657-D38A4791-F8F4-4FE2-9240-C2F9C205B46DQ33940563-CBFBB54B-7F2A-49D7-B922-ABEA2C8401D3Q33956306-36AF9A9B-67A1-4AB1-AA24-F62E9E6D8454Q34164457-E2552BD3-1E13-446D-B699-720346D35399Q34164521-83982B25-A81C-42C0-9093-4D8A9E2D304EQ34164575-E7F867B0-7DEA-43C0-A1EA-101A1F3DC1A1Q34332618-037970BC-F7BB-4695-9654-EF6A852E7717Q34435947-D3E90BB4-81E8-40B9-A471-670B596231C6Q35212218-89755864-75A2-47D9-BA5C-F78130E92187Q35458425-9629963F-5EA2-4FAE-B8C0-1ECC71447129Q35945493-45707E2A-E5E2-48A8-B6B5-0A07955BF358Q36013283-EE7C3048-BA17-404C-ABF3-D3798D03569CQ36072569-FBA3E4C0-52CA-45DB-A288-92145F1E6AA4Q36081670-5AAACD96-89FA-4074-ABE0-7A45A5330F41Q36134368-781E4FCC-A46B-499E-8582-880E9E2B4785Q36180744-3F3CF932-FAFE-4B84-8D72-39210080AE02Q36247293-A049D442-5B68-421C-AC71-FBBE23B3D811Q36290012-04E8C2F6-1A6A-43BD-8FBD-AB2B4FCFD5D8Q36514299-E958630D-9C1A-4A3A-87B8-F406D707EA92Q36613417-18A02499-4E2F-4A75-82F7-4303EDD8C18CQ36690877-5645F5A8-12B3-40F8-AB90-41F6BA82BC7EQ36692759-D6407187-53CA-4A98-8498-496550E1ABB8Q36822729-85617233-DA5F-4D44-B6E0-AFAD361D9C9CQ37279172-B61F08DC-03B3-44E7-9D2D-A263B9F28F14Q37401016-4FE59670-206D-4BD9-B742-5B1081067313Q39155292-83E45A9A-DC54-4904-80A0-B68DC7D363D9Q39199106-BDA467AA-050D-4A1D-BC69-6CDEF244AF27Q41455223-1E1D02B7-112B-4BF2-902D-D9F37A5BADA4Q41497465-B1414E9E-8E39-484C-ABC8-0DAC35AC4684Q41712371-401DDBE7-361F-4309-9040-754AE091A196Q41887321-FB8EF683-45C4-493B-B78C-0C229D0FC49BQ42127581-4B29371F-3938-4654-A9AA-176ABC09AF06Q42712700-617A9C59-FC96-4A44-BCE0-5F19E2C93A3AQ47164217-5B304316-C78E-4D4D-9D42-211537D64B87Q50315172-622DB716-E411-4510-B9DF-3B9141E500E8
P2860
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@en
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@nl
type
label
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@en
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@nl
prefLabel
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@en
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@nl
P2093
P1476
Adjuvant chemotherapy of high- ...... titutional Osteosarcoma Study.
@en
P2093
Horowitz M
P407
P577
1991-09-01T00:00:00Z